171 related articles for article (PubMed ID: 36897879)
41. Evaluation of human papillomavirus DNA detection in samples obtained for routine Chlamydia trachomatis screening.
Söderlund-Strand A; Wikström A; Dillner J
J Clin Virol; 2015 Mar; 64():88-91. PubMed ID: 25728085
[TBL] [Abstract][Full Text] [Related]
42. Changes in cervical cytokine profiles following focused ultrasound treatment for high-risk human papillomavirus infection-related low-grade cervical lesions.
Wang W; Zhou H; Liu Y; Ren J; Chen L
Int J Gynaecol Obstet; 2023 Sep; 162(3):983-988. PubMed ID: 37010893
[TBL] [Abstract][Full Text] [Related]
43. Protein-protein interactions of HPV-
Khan AA; A Abuderman A; Ashraf MT; Khan Z
Future Microbiol; 2020 May; 15():509-520. PubMed ID: 32476479
[No Abstract] [Full Text] [Related]
44. Infections of the cervix uteri with human papillomavirus and Chlamydia trachomatis.
Claas EC; Melchers WJ; Niesters HG; van Muyden R; Stolz E; Quint WG
J Med Virol; 1992 May; 37(1):54-7. PubMed ID: 1320098
[TBL] [Abstract][Full Text] [Related]
45. Detection of Chlamydia trachomatis and herpes simplex virus type 1 or 2 in cervical samples in human papilloma virus (HPV)-positive and HPV-negative women.
Finan RR; Musharrafieh U; Almawi WY
Clin Microbiol Infect; 2006 Sep; 12(9):927-30. PubMed ID: 16882302
[TBL] [Abstract][Full Text] [Related]
46. [Expression of gamma interferon during HPV and Chlamydia trachomatis infection in cervical samples].
Colín-Ferreyra Mdel C; Mendieta-Zerón H; Romero-Figueroa Mdel S; Martínez-Madrigal M; Martínez-Pérez S; Domínguez-García MV
Enferm Infecc Microbiol Clin; 2015 Feb; 33(2):105-9. PubMed ID: 25541008
[TBL] [Abstract][Full Text] [Related]
47. Correlation analysis of vaginal flora and immune function Th1/Th2 imbalance in women with high-risk HPV infections in the female reproductive tract.
Zheng J; Zhao R; Deng C
Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):128-133. PubMed ID: 38372108
[TBL] [Abstract][Full Text] [Related]
48. Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection.
Jha R; Srivastava P; Salhan S; Finckh A; Gabay C; Mittal A; Bas S
Microbes Infect; 2011 Feb; 13(2):167-78. PubMed ID: 21034849
[TBL] [Abstract][Full Text] [Related]
49. Prevalence of Chlamydia trachomatis and oncogenic human papillomavirus types in cytologic atypia of the uterine cervix.
Fehér E; Szalmás A
Acta Microbiol Immunol Hung; 2006 Dec; 53(4):479-87. PubMed ID: 17278714
[TBL] [Abstract][Full Text] [Related]
50. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines.
Smith JS; Muñoz N; Herrero R; Eluf-Neto J; Ngelangel C; Franceschi S; Bosch FX; Walboomers JM; Peeling RW
J Infect Dis; 2002 Feb; 185(3):324-31. PubMed ID: 11807714
[TBL] [Abstract][Full Text] [Related]
51. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma.
Wallin KL; Wiklund F; Luostarinen T; Angström T; Anttila T; Bergman F; Hallmans G; Ikäheimo I; Koskela P; Lehtinen M; Stendahl U; Paavonen J; Dillner J
Int J Cancer; 2002 Oct; 101(4):371-4. PubMed ID: 12209962
[TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus and chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study.
Waisberg MG; Ribeiro AC; Candido WM; Medeiros PB; Matsuzaki CN; Beldi MC; Tacla M; Caiaffa-Filho HH; Bonfa E; Silva CA
Rheumatol Int; 2015 Mar; 35(3):459-63. PubMed ID: 25348220
[TBL] [Abstract][Full Text] [Related]
53. [Human papilloma virus and Chlamydia trachomatis by number of sexual partners and time of sexual activity on university students in the Region of La Araucanía, Chile].
Melo A; Lagos N; Montenegro S; Orellana JJ; Vásquez AM; Moreno S; Liempi S; Guzmán P; Fonseca-Salamanca F
Rev Chilena Infectol; 2016 Jun; 33(3):287-92. PubMed ID: 27598277
[TBL] [Abstract][Full Text] [Related]
54. The female lower genital tract is a privileged compartment with IL-10 producing dendritic cells and poor Th1 immunity following Chlamydia trachomatis infection.
Marks E; Tam MA; Lycke NY
PLoS Pathog; 2010 Nov; 6(11):e1001179. PubMed ID: 21079691
[TBL] [Abstract][Full Text] [Related]
55. Cytokines profiles in cervical mucosa in patients with cervical high-risk human papillomavirus infection.
Long DL; Song HL; Qu PP
J Infect Dev Ctries; 2021 May; 15(5):719-725. PubMed ID: 34106897
[TBL] [Abstract][Full Text] [Related]
56. Chlamydia trachomatis as a probable cofactor in human papillomavirus infection in aboriginal women from northeastern Argentina.
Deluca GD; Basiletti J; Schelover E; Vásquez ND; Alonso JM; Marín HM; Lucero RH; Picconi MA
Braz J Infect Dis; 2011; 15(6):567-72. PubMed ID: 22218516
[TBL] [Abstract][Full Text] [Related]
57. Correlation of high-risk human papilloma viruses but not of herpes viruses or Chlamydia trachomatis with endometriosis lesions.
Oppelt P; Renner SP; Strick R; Valletta D; Mehlhorn G; Fasching PA; Beckmann MW; Strissel PL
Fertil Steril; 2010 Apr; 93(6):1778-86. PubMed ID: 19200955
[TBL] [Abstract][Full Text] [Related]
58. Modulation of cytokines and transcription factors (T-Bet and GATA3) in CD4 enriched cervical cells of Chlamydia trachomatis infected fertile and infertile women upon stimulation with chlamydial inclusion membrane proteins B and C.
Gupta R; Vardhan H; Srivastava P; Salhan S; Mittal A
Reprod Biol Endocrinol; 2009 Aug; 7():84. PubMed ID: 19698128
[TBL] [Abstract][Full Text] [Related]
59. High-throughput monitoring of human papillomavirus type distribution.
Söderlund-Strand A; Dillner J
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):242-50. PubMed ID: 23221127
[TBL] [Abstract][Full Text] [Related]
60. Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage.
Vicetti Miguel RD; Quispe Calla NE; Pavelko SD; Cherpes TL
PLoS One; 2016; 11(9):e0162445. PubMed ID: 27606424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
